JPRN-UMIN000026799已完成3 期
A randomized phse 3 study of carboplatin plus nab-paclitaxel with or without nintedanib for advanced non-small-cell lung cancer with idiopathic pulmonary fibrosis - Japanese Intergroup Study of Nintedanib for NSCLC with IPF (J-SONIC)
Research Institute for Diseases of the Chest, Kyushu University0 个研究点目标入组 243 人开始时间: 2017年4月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 243
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Ground glass opacity is less extensive than reticular opacity pattern 2) History of acute exacerbation of IPF 3) Other interstitial lung disease of known etiology including infection, pneumoconiosis, drug-induced pneumonitis, sarcoidosis, and collagen vascular disease 4) Synchronous or metachronous active double malignancies 5) With serious complications 6) With high bleeding risks 7) Local or systemic active infection that requires treatment 8) Pregnant, possibly pregnant or breastfeeding, or unwilling to practice contraception during the study 9) Severe psychiatric diseases 10) History of serious drug allergies 11) Other conditions not suitable for this study
研究者
相似试验
进行中（未招募）
1 期
Veliparib in combination with carboplatin and paclitaxel and as continuation maintenance therapy in subjects with newly diagnosed, untreated Stage III or IV high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancerewly diagnosed, untreated Stage III or IV high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancerEUCTR2014-005070-11-PLAbbVie Deutschland GmbH & Co. KG1,100
进行中（未招募）
1 期
Veliparib in combination with carboplatin and paclitaxel and as continuation maintenance therapy in subjects with newly diagnosed, untreated Stage III or IV high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancerEUCTR2014-005070-11-DKAbbVie Deutschland GmbH & Co. KG1,100
进行中（未招募）
1 期
Veliparib in combination with carboplatin and paclitaxel and as continuation maintenance therapy in subjects with newly diagnosed, untreated Stage III or IV high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancerewly diagnosed, untreated Stage III or IV high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancerEUCTR2014-005070-11-ESAbbVie Deutschland GmbH & Co. KG1,100
未知
2 期
Phase II study in combination with Carboplatin and TS-1 for Cancer of unknown primaryCancer of unknown primaryJPRN-UMIN000001236ational Cancer Center Hospital, Tokyo35
已完成
3 期
A phase III study comparing carboplatin plus pemetrexed followed by maintenance pemetrexed with docetaxel in elderly patients with advanced non-squamous non-small-cell lung cancer (JCOG1210/WJOG7813L CBDCA/PEM vs DOC Phase III)Elderly patients with advanced non-squamous non-small-cell lung cancerJPRN-UMIN000011460Japan Clinical Oncology Group (JCOG)430